COSMOS Pharmaceutical (TSE:3349) LT-Debt-to-Total-Asset : 0.02 (As of Feb. 2024)

View and export this data going back to 2004. Start your Free Trial

What is COSMOS Pharmaceutical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. COSMOS Pharmaceutical's long-term debt to total assests ratio for the quarter that ended in Feb. 2024 was 0.02.

COSMOS Pharmaceutical's long-term debt to total assets ratio increased from Feb. 2023 (0.01) to Feb. 2024 (0.02). It may suggest that COSMOS Pharmaceutical is progressively becoming more dependent on debt to grow their business.

COSMOS Pharmaceutical LT-Debt-to-Total-Asset Historical Data

The historical data trend for COSMOS Pharmaceutical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical LT-Debt-to-Total-Asset Chart

COSMOS Pharmaceutical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.04

0.03

0.02

0.03

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.03	0.02	0.02	0.02

COSMOS Pharmaceutical LT-Debt-to-Total-Asset Calculation

COSMOS Pharmaceutical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in May. 2023 is calculated as

LT Debt to Total Assets (A: May. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: May. 2023 )	/	Total Assets (A: May. 2023 )
	=	13716	/	420967
	=	0.03

COSMOS Pharmaceutical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

LT Debt to Total Assets (Q: Feb. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Feb. 2024 )	/	Total Assets (Q: Feb. 2024 )
	=	7962	/	430241
	=	0.02

COSMOS Pharmaceutical (TSE:3349) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

COSMOS Pharmaceutical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

COSMOS Pharmaceutical (TSE:3349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013

Website

http://www.cosmospc.co.jp

COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines